Skip to main content
. 2022 Dec 5;29(Suppl):S184–S195. doi: 10.3350/cmh.2022.0318

Table 2.

Variants in NAFLD/NASH-associated genes and regulation of gene expression in immune related loci

Tissue Gene expression Sample size P-value
SNP ID: rs738409 hg19_coordinates: chr22:44324727 (PNPLA3)
Adipose subcutaneous SAMM50 385 9.60E-07
Whole blood SAMM50 5,257 5.67E-106
Whole blood SAMM50 31,300 3.15E-18
Whole blood FAM89B 31,300 5.49E-06
SNP ID: rs58542926 hg19_coordinates: chr19:19379549 (TM6SF2)
Whole blood CXCL9 5,257 3.13E-06
Whole blood CXCL16 28,533 5.71E-06
SNP ID: rs641738 hg19_coordinates: chr19:54676763 (TMC4/MBOAT7)
Whole blood LILRP1 5,417 8.87E-06

Variant: rs738409, gene: PNPLA3. Variant: rs58542926, gene: TM6SF2. Variant: rs72613567, gene: HSD17B13. Variant: rs641738, gene: MBOAT4/TMC4.

SNP, single nucleotide polymorphism; PNPLA3, patatin-like phospholipase domain containing 3; TM6SF2, transmembrane 6 superfamily member 2; MBOAT7, membrane bound O-acyltransferase domain containing 7; TMC4, transmembrane channel-like 4; NAFLD, nonalcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis.

Information was retrieved from http://www.phenoscanner.medschl.cam.ac.uk/, a curated database holding publicly available results from large-scale genome-wide association studies. [45,46]